BACKGROUND: Accurate prediction of future glucose concentration for type 1 diabetes mellitus (T1DM) is needed to improve glycemic control and to facilitate proactive management before glucose concentrations reach undesirable concentrations. The availability of frequent glucose measurements, insulin infusion rates, and meal carbohydrate estimates can be used to good advantage to capture important information concerning glucose dynamics. METHODS: This article evaluates the feasibility of using a latent variable (LV)-based statistical method to model glucose dynamics and to forecast future glucose concentrations for T1DM applications. The prediction models are developed using a proposed LV-based approach and are evaluated for retrospective clinical data from seven individuals with T1DM and for In silico simulations using the Food and Drug Administration-accepted University of Virginia/University of Padova metabolic simulator. This article provides comparisons of the prediction accuracy of the LV-based method with that of a standard modeling alternative. The influence of key design parameters on the performance of the LV-based method is also illustrated. RESULTS: In general, the LV-based method provided improved prediction accuracy in comparison with conventional autoregressive (AR) models and autoregressive with exogenous input (ARX) models. For larger prediction horizons (≥30 min), the LV-based model with exogenous inputs achieved the best prediction performance based on a paired t-test (α = 0.05). CONCLUSIONS: The LV-based method resulted in models whose glucose prediction accuracy was as least as good as the accuracies of standard AR/ARX models and a simple model-free approach. Furthermore, the new approach is less sensitive to changing conditions and the effect of key design parameters.
BACKGROUND: Accurate prediction of future glucose concentration for type 1 diabetes mellitus (T1DM) is needed to improve glycemic control and to facilitate proactive management before glucose concentrations reach undesirable concentrations. The availability of frequent glucose measurements, insulin infusion rates, and meal carbohydrate estimates can be used to good advantage to capture important information concerning glucose dynamics. METHODS: This article evaluates the feasibility of using a latent variable (LV)-based statistical method to model glucose dynamics and to forecast future glucose concentrations for T1DM applications. The prediction models are developed using a proposed LV-based approach and are evaluated for retrospective clinical data from seven individuals with T1DM and for In silico simulations using the Food and Drug Administration-accepted University of Virginia/University of Padova metabolic simulator. This article provides comparisons of the prediction accuracy of the LV-based method with that of a standard modeling alternative. The influence of key design parameters on the performance of the LV-based method is also illustrated. RESULTS: In general, the LV-based method provided improved prediction accuracy in comparison with conventional autoregressive (AR) models and autoregressive with exogenous input (ARX) models. For larger prediction horizons (≥30 min), the LV-based model with exogenous inputs achieved the best prediction performance based on a paired t-test (α = 0.05). CONCLUSIONS: The LV-based method resulted in models whose glucose prediction accuracy was as least as good as the accuracies of standard AR/ARX models and a simple model-free approach. Furthermore, the new approach is less sensitive to changing conditions and the effect of key design parameters.
Authors: Scott M Pappada; Brent D Cameron; Paul M Rosman; Raymond E Bourey; Thomas J Papadimos; William Olorunto; Marilyn J Borst Journal: Diabetes Technol Ther Date: 2011-02 Impact factor: 6.118
Authors: William L Clarke; Stacey Anderson; Leon Farhy; Marc Breton; Linda Gonder-Frederick; Daniel Cox; Boris Kovatchev Journal: Diabetes Care Date: 2005-10 Impact factor: 19.112
Authors: Adiwinata Gani; Andrei V Gribok; Srinivasan Rajaraman; W Kenneth Ward; Jaques Reifman Journal: IEEE Trans Biomed Eng Date: 2008-09-16 Impact factor: 4.538
Authors: Daniel A Finan; Howard Zisser; Lois Jovanovic; Wendy C Bevier; Dale E Seborg Journal: Diabetes Technol Ther Date: 2007-10 Impact factor: 6.118
Authors: J Ignacio Hidalgo; J Manuel Colmenar; Gabriel Kronberger; Stephan M Winkler; Oscar Garnica; Juan Lanchares Journal: J Med Syst Date: 2017-08-08 Impact factor: 4.460
Authors: Eleni I Georga; Vasilios C Protopappas; Demosthenes Polyzos; Dimitrios I Fotiadis Journal: Med Biol Eng Comput Date: 2015-03-15 Impact factor: 2.602
Authors: Xiaoyu Sun; Mudassir Rashid; Nicole Hobbs; Mohammad Reza Askari; Rachel Brandt; Andrew Shahidehpour; Ali Cinar Journal: Control Eng Pract Date: 2021-09-11 Impact factor: 4.057